vs

Side-by-side financial comparison of Roper Technologies (ROP) and Xylem Inc. (XYL). Click either name above to swap in a different company.

Xylem Inc. is the larger business by last-quarter revenue ($2.1B vs $2.1B, roughly 1.0× Roper Technologies). Roper Technologies runs the higher net margin — 15.8% vs 8.9%, a 6.9% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs 2.7%). Over the past eight quarters, Roper Technologies's revenue compounded faster (10.5% CAGR vs -1.0%).

Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.

ROP vs XYL — Head-to-Head

Bigger by revenue
XYL
XYL
1.0× larger
XYL
$2.1B
$2.1B
ROP
Growing faster (revenue YoY)
ROP
ROP
+8.6% gap
ROP
11.3%
2.7%
XYL
Higher net margin
ROP
ROP
6.9% more per $
ROP
15.8%
8.9%
XYL
Faster 2-yr revenue CAGR
ROP
ROP
Annualised
ROP
10.5%
-1.0%
XYL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ROP
ROP
XYL
XYL
Revenue
$2.1B
$2.1B
Net Profit
$331.0M
$189.0M
Gross Margin
69.4%
37.8%
Operating Margin
27.2%
11.5%
Net Margin
15.8%
8.9%
Revenue YoY
11.3%
2.7%
Net Profit YoY
842.6%
13.2%
EPS (diluted)
$4.87
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ROP
ROP
XYL
XYL
Q1 26
$2.1B
$2.1B
Q4 25
$2.1B
$2.4B
Q3 25
$2.0B
$2.3B
Q2 25
$1.9B
$2.3B
Q1 25
$1.9B
$2.1B
Q4 24
$1.9B
$2.3B
Q3 24
$1.8B
$2.1B
Q2 24
$1.7B
$2.2B
Net Profit
ROP
ROP
XYL
XYL
Q1 26
$331.0M
$189.0M
Q4 25
$428.4M
$335.0M
Q3 25
$398.5M
$227.0M
Q2 25
$378.3M
$226.0M
Q1 25
$331.1M
$169.0M
Q4 24
$462.3M
$326.0M
Q3 24
$367.9M
$217.0M
Q2 24
$337.1M
$194.0M
Gross Margin
ROP
ROP
XYL
XYL
Q1 26
69.4%
37.8%
Q4 25
69.5%
38.9%
Q3 25
69.5%
38.9%
Q2 25
69.2%
38.8%
Q1 25
68.7%
37.1%
Q4 24
68.3%
38.0%
Q3 24
69.2%
37.3%
Q2 24
69.5%
37.8%
Operating Margin
ROP
ROP
XYL
XYL
Q1 26
27.2%
11.5%
Q4 25
28.6%
14.7%
Q3 25
28.4%
14.7%
Q2 25
28.2%
13.3%
Q1 25
27.9%
11.2%
Q4 24
28.0%
11.8%
Q3 24
28.1%
13.3%
Q2 24
28.8%
11.7%
Net Margin
ROP
ROP
XYL
XYL
Q1 26
15.8%
8.9%
Q4 25
20.8%
14.0%
Q3 25
19.8%
10.0%
Q2 25
19.5%
9.8%
Q1 25
17.6%
8.2%
Q4 24
24.6%
14.5%
Q3 24
20.8%
10.3%
Q2 24
19.6%
8.9%
EPS (diluted)
ROP
ROP
XYL
XYL
Q1 26
$4.87
$0.79
Q4 25
$3.97
$1.37
Q3 25
$3.68
$0.93
Q2 25
$3.49
$0.93
Q1 25
$3.06
$0.69
Q4 24
$4.29
$1.33
Q3 24
$3.40
$0.89
Q2 24
$3.12
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ROP
ROP
XYL
XYL
Cash + ST InvestmentsLiquidity on hand
$382.9M
$808.0M
Total DebtLower is stronger
$9.7B
$1.9B
Stockholders' EquityBook value
$18.8B
$11.0B
Total Assets
$34.6B
$17.0B
Debt / EquityLower = less leverage
0.52×
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ROP
ROP
XYL
XYL
Q1 26
$382.9M
$808.0M
Q4 25
$297.4M
$1.5B
Q3 25
$320.0M
$1.2B
Q2 25
$242.4M
$1.2B
Q1 25
$372.8M
$1.1B
Q4 24
$188.2M
$1.1B
Q3 24
$269.6M
$989.0M
Q2 24
$251.5M
$815.0M
Total Debt
ROP
ROP
XYL
XYL
Q1 26
$9.7B
$1.9B
Q4 25
$9.3B
$2.0B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$7.6B
$2.0B
Q3 24
Q2 24
Stockholders' Equity
ROP
ROP
XYL
XYL
Q1 26
$18.8B
$11.0B
Q4 25
$19.9B
$11.5B
Q3 25
$20.0B
$11.2B
Q2 25
$19.6B
$11.1B
Q1 25
$19.2B
$10.8B
Q4 24
$18.9B
$10.6B
Q3 24
$18.5B
$10.6B
Q2 24
$18.1B
$10.3B
Total Assets
ROP
ROP
XYL
XYL
Q1 26
$34.6B
$17.0B
Q4 25
$34.6B
$17.6B
Q3 25
$34.6B
$17.3B
Q2 25
$33.2B
$17.2B
Q1 25
$31.4B
$16.6B
Q4 24
$31.3B
$16.5B
Q3 24
$31.6B
$16.0B
Q2 24
$29.8B
$15.8B
Debt / Equity
ROP
ROP
XYL
XYL
Q1 26
0.52×
0.18×
Q4 25
0.47×
0.17×
Q3 25
0.18×
Q2 25
0.18×
Q1 25
0.19×
Q4 24
0.40×
0.19×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ROP
ROP
XYL
XYL
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$507.0M
FCF MarginFCF / Revenue
24.2%
Capex IntensityCapex / Revenue
0.5%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ROP
ROP
XYL
XYL
Q1 26
Q4 25
$738.0M
$543.0M
Q3 25
$869.5M
$360.0M
Q2 25
$404.1M
$305.0M
Q1 25
$528.7M
$33.0M
Q4 24
$722.2M
$575.0M
Q3 24
$755.4M
$311.0M
Q2 24
$384.1M
$288.0M
Free Cash Flow
ROP
ROP
XYL
XYL
Q1 26
$507.0M
Q4 25
$460.0M
Q3 25
$281.0M
Q2 25
$207.0M
Q1 25
$-38.0M
Q4 24
$475.0M
Q3 24
$237.0M
Q2 24
$215.0M
FCF Margin
ROP
ROP
XYL
XYL
Q1 26
24.2%
Q4 25
19.2%
Q3 25
12.4%
Q2 25
9.0%
Q1 25
-1.8%
Q4 24
21.1%
Q3 24
11.3%
Q2 24
9.9%
Capex Intensity
ROP
ROP
XYL
XYL
Q1 26
0.5%
4.2%
Q4 25
3.5%
Q3 25
3.5%
Q2 25
4.3%
Q1 25
3.4%
Q4 24
4.4%
Q3 24
3.5%
Q2 24
3.4%
Cash Conversion
ROP
ROP
XYL
XYL
Q1 26
Q4 25
1.72×
1.62×
Q3 25
2.18×
1.59×
Q2 25
1.07×
1.35×
Q1 25
1.60×
0.20×
Q4 24
1.56×
1.76×
Q3 24
2.05×
1.43×
Q2 24
1.14×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ROP
ROP

Segment breakdown not available.

XYL
XYL

Revenue from products$1.8B83%
Revenue from services$368.0M17%

Related Comparisons